Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Viracta Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 40 | 3 | 38 | +1 |
| Shares | 9.03M | 287.3K | 5.59M | −3.15M (−36.1%) |
| Value | $4.91M | $156.2K | $1.29M | −$3.46M (−72.8%) |
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Viracta Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 500,000 | $115.7K | 0.07% |
| BlackRock, Inc. | 234,846 | $54.3K | 0.00% |
| HRT Financial LP | 138,822 | $32.0K | 0.00% |
| Landscape Capital Management, L.L.C. | 68,317 | $15.8K | 0.00% |
| United Capital Financial Advisers, LLC | 42,995 | $9.89K | 0.00% |
| Goldman Sachs Group Inc | 27,090 | $6.27K | 0.00% |
| Colony Group, LLC | 14,000 | $3.24K | 0.00% |
| Dunhill Financial, LLC | 5,000 | $1.16K | 0.00% |
| Oarsman Capital, Inc. | 1,000 | $231 | 0.00% |
| Jones Financial Companies LLLP | 1,000 | $222 | 0.00% |
| Planned Solutions, Inc. | 1 | $0 | 0.00% |
Sold out (10)
Institutions that held Viracta Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BVF Inc | 3,614,662 | $1.97M |
| Bridgeway Capital Management, LLC | 74,000 | $40.2K |
| Ensign Peak Advisors, Inc | 61,601 | $33.5K |
| Virtu Financial LLC | 30,789 | $17.0K |
| MAI Capital Management | 27,417 | $14.9K |
| Beacon Pointe Advisors, LLC | 15,000 | $8.16K |
| Simplex Trading, LLC | 7,337 | $3.00K |
| Barclays PLC | 2,668 | $1.45K |
| GWM Advisors LLC | 14 | $8 |
| Qube Research & Technologies Ltd | 2 | $1 |
Not filed for Q3 2024 yet (3)
Institutions that held Viracta Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 273,297 | $148.6K |
| Hoylecohen, LLC | 14,000 | $7.61K |
| Private Ocean, LLC | 3 | $2 |